Biologic response modifiers in the therapy of metastatic renal cell carcinoma.
Quesada
J R
JR
Department of Clinical Immunology and Biology Therapy, University of Texas M.D. Anderson Hospital and Tumor Institute, Houston 77030.
D000276:Adjuvants, Immunologic / Q000627:therapeutic use; D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D001688:Biological Products / Q000627:therapeutic use; D002292:Carcinoma, Renal Cell / Q000276:immunology / Q000628:therapy*; D016207:Cytokines; D006801:Humans; D007167:Immunotherapy; D007372:Interferons / Q000627:therapeutic use; D007376:Interleukin-2 / Q000627:therapeutic use; D007680:Kidney Neoplasms / Q000276:immunology / Q000628:therapy*; D014612:Vaccines
D000276:Adjuvants, Immunologic; D000911:Antibodies, Monoclonal; D001688:Biological Products; D016207:Cytokines; D007376:Interleukin-2; D014612:Vaccines; D007372:Interferons